tiprankstipranks
OrganoClick AB (SE:ORGC)
:ORGC
Want to see SE:ORGC full AI Analyst Report?

OrganoClick AB (ORGC) Price & Analysis

0 Followers

ORGC Stock Chart & Stats

kr1.78
kr0.00(0.00%)
At close: 4:00 PM EST
kr1.78
kr0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Improving Cash GenerationOperating cash flow turning positive after a prior negative year shows the core business is beginning to generate cash from operations. This improves near-term liquidity, supports working-capital needs, and reduces immediate refinancing pressure, aiding structural viability while free cash flow remains a work in progress.
Sizable Asset BaseA material asset base provides tangible capacity to scale production, collateral for financing, and room to invest in commercialization. Assets can support operational expansion or restructurings and give management optionality to pursue partnerships or asset-backed funding when executing long-term growth plans.
Structurally Advantaged Product FocusOrganoClick's focus on bio‑based chemistries targets durable secular trends toward sustainability and tighter chemical regulations. Replacing fossil-based inputs in textiles and wood addresses long-term demand drivers from brands and regulators, offering a structural tailwind if the company can commercialize and scale its solutions.
Bears Say
Declining And Inconsistent RevenueA continuing revenue decline and multi-year inconsistency undermine scale economics and make it harder to achieve profitable operations. Weak top-line trends limit the ability to leverage fixed costs, complicate forecasting and commercial investments, and impair the path to sustainable profitability absent reliable revenue recovery.
Low Margins And Deep LossesLow gross margins and steep net losses point to constrained earnings power and limited pricing or cost advantage today. Persistent negative margins erode equity, reduce reinvestment capacity, and mean the business requires significant margin improvement or volume gains to reach break-even and fund growth sustainably.
Very High Leverage And Thin Equity CushionExtremely high debt relative to equity materially elevates financial risk, constrains strategic flexibility, and raises refinancing and covenant vulnerability. Interest and principal obligations limit capital available for R&D and commercialization, and a thin equity buffer magnifies downside in adverse industry or operational scenarios.

ORGC FAQ

What was OrganoClick AB’s price range in the past 12 months?
OrganoClick AB lowest stock price was kr0.33 and its highest was kr2.18 in the past 12 months.
    What is OrganoClick AB’s market cap?
    OrganoClick AB’s market cap is kr47.74M.
      When is OrganoClick AB’s upcoming earnings report date?
      OrganoClick AB’s upcoming earnings report date is Aug 12, 2026 which is in 42 days.
        How were OrganoClick AB’s earnings last quarter?
        OrganoClick AB released its earnings results on May 06, 2026. The company reported -kr0.015 earnings per share for the quarter, beating the consensus estimate of -kr0.02 by kr0.005.
          Is OrganoClick AB overvalued?
          According to Wall Street analysts OrganoClick AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does OrganoClick AB pay dividends?
            OrganoClick AB does not currently pay dividends.
            What is OrganoClick AB’s EPS estimate?
            OrganoClick AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does OrganoClick AB have?
            OrganoClick AB has 110,003,010 shares outstanding.
              What happened to OrganoClick AB’s price movement after its last earnings report?
              OrganoClick AB reported an EPS of -kr0.015 in its last earnings report, beating expectations of -kr0.02. Following the earnings report the stock price went up 6.371%.
                Which hedge fund is a major shareholder of OrganoClick AB?
                Currently, no hedge funds are holding shares in SE:ORGC
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  OrganoClick AB

                  OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, technical textiles, nonwovens, and biocomposites. Its diverse product portfolio includes OrganoWood, a wood preservation system that enhances wood's resistance to both rot and fire, primarily serving the construction industry and consumers. OrganoTex offers a biodegradable durable water repellent (DWR) technology for textiles, alongside related shoe and clothing care items. Additionally, OrganoComp is a biobased, plastic-free, and compostable composite designed to replace rigid plastics in 3D-molded products. For consumers, the BIOkleen brand provides a range of maintenance and cleaning solutions for wood, facades, roofs, terraces, and car care. Industrial clients benefit from OC-BioBinder, a biodegradable and plastic-free binder used in nonwovens and technical textiles as an alternative to conventional plastic binders, and OC-AquaSil Tex, a biodegradable water-repelling product that replaces PFAS chemicals in nonwovens, specialty papers, and technical textiles.

                  OrganoClick AB (ORGC) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Nexam Chemical Holding AB
                  Svenska Aerogel Holding AB
                  Polygiene AB
                  Impact Coatings AB
                  XP Chemistries AB
                  Popular Stocks